title: Elimination of alloreactive T cells using photodynamic therapy.
abstract: GvHD, the most important cause of morbidity and mortality after allogeneic stem cell transplantation, depends primarily on the ability of a donor T-cell subset to react to immunogenic host Ag. Recently developed culture conditions and treatment strategies may bring us closer to the selective elimination of such alloreactive T cells, often considered the holy grail of transplantation. Among the various therapeutic modalities, photodynamic therapy (PDT) offers a biological and global approach to the eradication of unwanted allo-activated T cells by combining mitochondrial targeting, P-glycoprotein inhibition and reactive oxygen species production. Indeed, the high potency of PDT against malignant cells has been harnessed to exert selective and extensive elimination of alloreactive T-cell subsets mediating GvHD, while preserving resting T cells with the ability to reconstitute the immune system for GvL activity and prevent or suppress viruses and fungi. The present paper reviews the basis of the PDT strategy, and the methodology employed. In vitro and in vivo studies that formed the proof of principle as a basis for human studies to investigate the clinical potential of PDT in the context of GvHD will be presented together with insights into future clinical applications of this versatile treatment platform.
authors.affiliation: Division of Hematology-Immunology, Department of Medicine, Guy-Bernier Research Center, Hôpital Maisonneuve-Rosemont, University of Montreal, 5415 L'Assomption Boulevard, Montreal, Quebec, Canada H1T 2M4.
authors.forename: R Sidi
authors.initials: RS
authors.lastname: Boumédine
authors.forename: D C
authors.initials: DC
authors.lastname: Roy
mesh_terms: D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control*; D020544:Graft vs Leukemia Effect / Q000187:drug effects / Q000276:immunology; D006801:Humans; D008212:Lymphocyte Depletion / Q000379:methods*; D010778:Photochemotherapy / Q000379:methods; D017319:Photosensitizing Agents / Q000627:therapeutic use; D020127:Recovery of Function / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology / Q000637:transplantation*; D014184:Transplantation, Homologous
chemical_list: D017319:Photosensitizing Agents